DNA-binding dependent and independent functions of WT1 protein during human hematopoiesis

被引:18
作者
Svensson, E
Eriksson, H
Gekas, C
Olofsson, T
Richter, J
Gullberg, U
机构
[1] Lund Univ, Dept Hematol, BMC, S-22184 Lund, Sweden
[2] Lund Univ, Dept Mol Med & Gene Therapy, Lund, Sweden
关键词
Wilms tumor gene 1; leukemia; hematopoiesis; zinc-finger; differentiation;
D O I
10.1016/j.yexcr.2005.04.018
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The Wilms tumor gene I (WT1) encodes a zinc-finger-containing transcription factor highly expressed in immature hematopoietic progenitor cells. Overexpression and presence of somatic mutations in acute leukemia indicate a role for WT1 in the pathogenesis of leukemia. CD34(+) progenitor cells were transduced with one splice variant of human WT1 without the KTS insert in the zinc-finger domain, WT1(+/-), and with a deleted mutant of WT1 lacking the entire zinc-finger region, WT1(delZ), thus incapable of binding DNA. We show that inhibition of erythroid colony formation and differentiation is absolutely dependent on the DNA-binding zinc-finger domain of WT1. Unexpectedly, however, WT1(delZ) was equally effective as wild type protein in the reduction of myeloid clonogenic growth as well as in stimulation of myeloid differentiation, as judged by the expression of cell surface CD11b. Expression of neither WT1(+/-) nor WT1(delZ) upregulated mRNA for the cdk inhibitor p21(Waf1/Cip1) or P27(Kip1). Our results demonstrate that WT1 affects proliferation and differentiation in erythroid and myeloid cells by different molecular mechanisms, and suggest that mutations affecting the zinc-finger domain of WT1 could interfere with normal differentiation in the pathogenesis of leukemia. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:211 / 221
页数:11
相关论文
共 76 条
[1]   Role of the WT1 tumor suppressor in murine hematopoiesis [J].
Alberta, JA ;
Springett, GM ;
Rayburn, H ;
Natoli, TA ;
Loring, J ;
Kreidberg, JA ;
Housman, D .
BLOOD, 2003, 101 (07) :2570-2574
[2]   Mutation analysis of the WT1 gene in sporadic childhood leukaemia [J].
Algar, E ;
Blackburn, D ;
Kromykh, T ;
Taylor, G ;
Smith, P .
LEUKEMIA, 1997, 11 (01) :110-113
[3]   A RAPID MICROPREPARATION TECHNIQUE FOR EXTRACTION OF DNA-BINDING PROTEINS FROM LIMITING NUMBERS OF MAMMALIAN-CELLS [J].
ANDREWS, NC ;
FALLER, DV .
NUCLEIC ACIDS RESEARCH, 1991, 19 (09) :2499-2499
[4]  
Baird PN, 1997, EXP HEMATOL, V25, P312
[5]   MODULATION OF DNA-BINDING SPECIFICITY BY ALTERNATIVE SPLICING OF THE WILMS-TUMOR WT1 GENE TRANSCRIPT [J].
BICKMORE, WA ;
OGHENE, K ;
LITTLE, MH ;
SEAWRIGHT, A ;
VANHEYNINGEN, V ;
HASTIE, ND .
SCIENCE, 1992, 257 (5067) :235-237
[6]   The Wilms' tumor gene is frequently expressed in acute myeloblastic leukemias and may provide a marker for residual blast cells detectable by PCR [J].
Brieger, J ;
Weidmann, E ;
Maurer, U ;
Hoelzer, D ;
Mitrou, PS ;
Bergmann, L .
ANNALS OF ONCOLOGY, 1995, 6 (08) :811-816
[7]  
BRIEGER J, 1994, LEUKEMIA, V8, P2138
[8]   RNA binding by the Wilms tumor suppressor zinc finger proteins [J].
Caricasole, A ;
Duarte, A ;
Larsson, SH ;
Hastie, ND ;
Little, M ;
Holmes, G ;
Todorov, I ;
Ward, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (15) :7562-7566
[9]   BASP1 is a transcriptional cosuppressor for the Wilms' tumor suppressor protein WT1 [J].
Carpenter, B ;
Hill, KJ ;
Charalambous, M ;
Wagner, KJ ;
Lahiri, D ;
James, DI ;
Andersen, JS ;
Schumacher, V ;
Royer-Pokora, B ;
Mann, M ;
Ward, A ;
Roberts, SGE .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (02) :537-549
[10]  
Chylicki K, 2000, CELL GROWTH DIFFER, V11, P315